首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   35873篇
  免费   2886篇
  国内免费   114篇
耳鼻咽喉   246篇
儿科学   1150篇
妇产科学   815篇
基础医学   5013篇
口腔科学   592篇
临床医学   4336篇
内科学   7579篇
皮肤病学   717篇
神经病学   3784篇
特种医学   691篇
外科学   3436篇
综合类   293篇
一般理论   41篇
预防医学   4057篇
眼科学   565篇
药学   2701篇
中国医学   54篇
肿瘤学   2803篇
  2023年   381篇
  2022年   597篇
  2021年   1276篇
  2020年   775篇
  2019年   1174篇
  2018年   1205篇
  2017年   864篇
  2016年   1017篇
  2015年   1116篇
  2014年   1405篇
  2013年   1813篇
  2012年   2860篇
  2011年   2825篇
  2010年   1506篇
  2009年   1283篇
  2008年   2203篇
  2007年   2261篇
  2006年   2218篇
  2005年   2055篇
  2004年   1907篇
  2003年   1661篇
  2002年   1486篇
  2001年   419篇
  2000年   353篇
  1999年   363篇
  1998年   304篇
  1997年   242篇
  1996年   217篇
  1995年   199篇
  1994年   151篇
  1993年   157篇
  1992年   209篇
  1991年   210篇
  1990年   178篇
  1989年   178篇
  1988年   149篇
  1987年   138篇
  1986年   140篇
  1985年   132篇
  1984年   127篇
  1983年   112篇
  1982年   87篇
  1981年   83篇
  1980年   61篇
  1979年   66篇
  1978年   69篇
  1976年   59篇
  1974年   52篇
  1973年   49篇
  1972年   48篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Achieving hepatitis C virus (HCV) elimination by 2030 requires an increased linkage to care for people who inject drugs (PWID). Project ITTREAT was established to mitigate barriers to HCV care by providing an integrated service within a local drug and alcohol treatment centre. This study aimed to explore the experiences of clients and staff involved in Project ITTREAT and assess the facilitators and barriers to a community‐based HCV service. Between October 2014 and April 2016, drug and alcohol treatment attendees were interviewed using one‐to‐one semi‐structured interviews. Drug and alcohol treatment staff took part in focus groups. All data were recorded, transcribed verbatim and analysed using thematic content analysis. Fifteen drug and alcohol treatment attendees with current/previous HCV infection were interviewed, and 15 staff members contributed across two focus groups. Drug and alcohol treatment staff and attendees reported that Project ITTREAT facilitated access to HCV care by mitigating previous negative hospital‐based experiences. Other key facilitators were positive narratives around HCV care, and drug and alcohol treatment attendees being well engaged in their drug/alcohol recovery. Barriers included a lack of stability in drug and alcohol treatment attendees, negative discourse around testing/treatment and stigma associated with attending the drug and alcohol treatment to access HCV treatment in some who had successfully achieved drug rehabilitation. Our findings indicate the positive impact of an integrated and personalized community‐based service delivered by a dedicated hepatitis nurse. This played a crucial role in reducing barriers to HCV care for PWID. Our work also highlights areas for future investment including non–DAT‐based community services and increasing awareness of new treatments amongst this cohort.  相似文献   
992.
993.
994.
995.
996.
997.
998.
Twenty‐seven patients with resistant hypertension and chronic kidney disease were treated by renal sympathetic denervation (RSD) and followed for 12 months. Patients were retrospectively divided into controlled and uncontrolled blood pressure (BP) groups. Increases in mean estimated glomerular filtration rate (eGFR) were found at months 1, 3, 6, and 12 in the controlled group (P<.0001, for every time point). The mean change in eGFR after 12 months was 18.54±8.15 mL/min/1.73m2 higher in the controlled group (P=.0318). In patients in the controlled group with baseline eGFR <45 mL/min/1.73 m2, responders (with an increase in eGFR >6.2%) corresponded to 50% at 6 months and 83% at 12 months. In the patients with baseline eGFR ≥45 mL/min/1.73 m2, all patients were labeled as responders at months 6 and 12. Median albumin:creatinine ratio after 12 months was lower than baseline only in the controlled group (P=.0003). Our results suggest that patients with this profile who reached BP control by RSD also experienced a significant improvement in renal function.  相似文献   
999.
Nonalcoholic steatohepatitis (NASH) is a frequent cause of cirrhosis and may lead to liver-related mortality. In Western countries, NASH is the most common liver disease and may progress to advanced fibrosis or cirrhosis in a significant portion of cases. Moreover, NASH, even in the absence of cirrhosis, is associated with the development of hepatocellular carcinoma. An increased risk of cardiovascular events and/or diabetes represents another major problem in these patients. In this review, we discuss recent data on the basic mechanisms leading to the development of fibrosis in nonalcoholic steatohepatitis, in particular those which may identify novel approaches to treatment.  相似文献   
1000.

Background and objectives

The term “nondisease-specific” has been used to describe problems that cross multiple domains of health and are not necessarily the result of a single underlying disease. Although individuals with reduced eGFR and elevated albumin-to-creatinine ratio have many comorbidities, the prevalence of and outcomes associated with nondisease-specific problems have not been well studied.

Design, setting, participants, & measurements

Participants included 3557 black and white United States adults ≥75 years of age from the Reasons for Geographic and Racial Differences in Stroke Study. Nondisease-specific problems included cognitive impairment, depressive symptoms, exhaustion, falls, impaired mobility, and polypharmacy. Hazard ratios for mortality over a median (interquartile range) of 5.4 (4.2–6.9) years of follow-up associated with one, two, or three to six nondisease-specific problems were calculated and stratified by eGFR (≥60, 45–59, and <45 ml/min per 1.73 m2) and separately, albumin-to-creatinine ratio (<30, 30–299, and ≥300 mg/g). Secondary outcomes included hospitalizations and emergency department visits over 1.8 (0.7–4.0) and 2.3 (0.9–4.7) years of follow-up, respectively.

Results

The prevalence of nondisease-specific problems was more common at lower eGFR and higher albumin-to-creatinine ratio levels. Within each eGFR and albumin-to-creatinine ratio strata, the risk for mortality was higher among those with a greater number of nondisease-specific problems. For example, among those with an eGFR=45–59 ml/min per 1.73 m2, the multivariable adjusted hazard ratios (95% confidence intervals) for mortality associated with one, two, or three to six nondisease-specific problems were 1.17 (0.78 to 1.76), 1.95 (1.24 to 3.07), and 2.44 (1.39 to 4.27; P trend <0.001). Risk for hospitalization and emergency department visits was higher among those with more nondisease-specific problems within eGFR and albumin-to-creatinine ratio strata.

Conclusions

Among older adults, nondisease-specific problems commonly co-occur with reduced eGFR and elevated albumin-to-creatinine ratio. Identification of nondisease-specific problems may provide mortality risk information independent of measures of kidney function.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号